Aptar Announces the Realignment of Two of its Business Reporting Segments
The Company’s Pharma Segment Remains Unchanged CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today announced that it will realign two of its business reporting segments effective January 1, 2023. Aptar’s two renamed reporting segments…
